paclitaxel has been researched along with farnesol in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marijnissen, JC; Wang, CH; Xie, J | 1 |
| Kloog, Y; Kraitzer, A; Zilberman, M | 1 |
| Haklai, R; Kloog, Y; Kraitzer, A; Zilberman, M | 1 |
| Alperstein, D; Kloog, Y; Kraitzer, A; Zilberman, M | 1 |
| Chen, Y; Gao, X; Huang, Y; Li, J; Li, S; Lu, J; Stolz, DB; Sun, M; Venkataramanan, R; Zhang, L; Zhang, X; Zhao, W | 1 |
| Chen, Y; Huang, Y; Li, J; Li, S; Venkataramanan, R; Zhang, P; Zhang, X; Zhao, W | 1 |
| Huang, Y; Li, J; Li, S; Liu, K; Ma, X; Xu, J; Zhang, X | 1 |
| Chen, Y; Fu, X; Huang, Y; Li, K; Li, S; Sun, J; Venkataramanan, R; Wei, Y; Xu, L; Zhang, P; Zhang, X; Zhao, W | 1 |
8 other study(ies) available for paclitaxel and farnesol
| Article | Year |
|---|---|
Microparticles developed by electrohydrodynamic atomization for the local delivery of anticancer drug to treat C6 glioma in vitro.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Biocompatible Materials; Brain Neoplasms; Calorimetry, Differential Scanning; Cell Cycle; Cell Division; Cell Line, Tumor; Cell Survival; Diazonium Compounds; Electrochemistry; Farnesol; G2 Phase; Glioma; Humans; Microscopy, Electron, Scanning; Microspheres; Models, Statistical; Molecular Weight; Paclitaxel; Polymers; Solvents; Spectrometry, X-Ray Emission; Surface Properties; Temperature; Time Factors | 2006 |
Novel farnesylthiosalicylate (FTS)-eluting composite structures.
Topics: Algorithms; Antineoplastic Agents, Phytogenic; Chemistry, Pharmaceutical; Drug Compounding; Drug Stability; Drug-Eluting Stents; Emulsions; Farnesol; Indicators and Reagents; Kinetics; Metals; Microscopy, Electron, Scanning; Paclitaxel; Porosity; Salicylates; Solubility; Tensile Strength | 2009 |
Composite fiber structures with antiproliferative agents exhibit advantageous drug delivery and cell growth inhibition in vitro.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Delivery Systems; Drug-Eluting Stents; Enzyme Inhibitors; Farnesol; Humans; Kinetics; Lactic Acid; Paclitaxel; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; ras Proteins; Rats; Salicylates; Solubility | 2011 |
Mechanisms of antiproliferative drug release from bioresorbable porous structures.
Topics: Antineoplastic Agents; Biocompatible Materials; Drug-Eluting Stents; Farnesol; Humans; Models, Molecular; Neoplasms; Paclitaxel; Polyglactin 910; Porosity; Salicylates; Sirolimus; Solubility | 2013 |
PEG-farnesylthiosalicylate conjugate as a nanomicellar carrier for delivery of paclitaxel.
Topics: Animals; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; Drug Delivery Systems; Farnesol; Female; HCT116 Cells; Humans; Mice; Mice, Inbred BALB C; Micelles; Paclitaxel; Polyethylene Glycols; Random Allocation; Rats; Salicylates | 2013 |
PEG-farnesyl thiosalicylic acid telodendrimer micelles as an improved formulation for targeted delivery of paclitaxel.
Topics: Animals; Breast Neoplasms; Disease Models, Animal; Drug Carriers; Farnesol; Female; HCT116 Cells; Hemolysis; Humans; Inhibitory Concentration 50; Magnetic Resonance Spectroscopy; Mammary Neoplasms, Experimental; MCF-7 Cells; Mice; Mice, Inbred BALB C; Micelles; Paclitaxel; Polyethylene Glycols; Salicylates | 2014 |
Reduction-sensitive dual functional nanomicelles for improved delivery of paclitaxel.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Drug Carriers; Farnesol; Female; Humans; Hydrophobic and Hydrophilic Interactions; Mammary Neoplasms, Experimental; Mice; Micelles; Nanostructures; Oxidation-Reduction; Paclitaxel; Polyethylene Glycols; Salicylates | 2014 |
A prodrug micellar carrier assembled from polymers with pendant farnesyl thiosalicylic acid moieties for improved delivery of paclitaxel.
Topics: Animals; Antineoplastic Agents; Cell Death; Cell Line, Tumor; Drug Delivery Systems; Drug Liberation; Dynamic Light Scattering; Farnesol; Humans; Kaplan-Meier Estimate; Mice; Micelles; Paclitaxel; Polyethylene Glycols; Polymerization; Polymers; Prodrugs; Proton Magnetic Resonance Spectroscopy; Salicylates; Spectroscopy, Near-Infrared | 2016 |